The Centre has stopped production of drugs at 31 firms and cancelled or suspended the product licenses of 50 firms on finding non-adherence to quality control norms. In addition, sources said, showcause notice has been issued to 73 firms, and warning letters have been issued against 21 firms.
from Times of India https://ift.tt/SrjuPUO
0 Comments